SAN DIEGO and SUZHOU, China, July 12, 2024 (GLOBE NEWSWIRE) -- Adagene Inc. (ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced a poster ...
PharmaJet needle-free technology can improve DNA vaccine delivery 1 and has been successfully adopted into multiple cancer vaccine development programs. Partner study data shows how PharmaJet ...
Sutro Biopharma, Inc. announced its participation in the 2025 American Association for Cancer Research Annual Meeting, presenting key data on its novel exatecan Tissue Factor antibody drug conjugate ...
EL MONTE, Calif.--(BUSINESS WIRE)-- Fulgent Genetics, Inc. (FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic ...
PharmaJet ®, a company that strives to improve the performance and outcomes of injectables with its enabling needle-free technology, today announced their upcoming poster presentation on November 13, ...
Hosted on MSN
IMRC 2025 concludes at IIMA with high-impact discussions, poster presentations, and diverse research perspectives
India, Dec. 7 -- ~ The concluding day featured a conference-wide poster presentation session, where over 80 participants presented their research across diverse areas of management The Indian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback